QVA149 versus glycopyrronium for COPD - authors' reply

Affiliations

¹ Centre for Respiratory Medicine, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: w.wedzicha@ucl.ac.uk.
² Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium.
³ Paracelsus Medical University Nuremberg, Nuremberg, Germany; Klinikum Nuernberg, Department of Respiratory Medicine, Allergology, Sleep Medicine, Nuernberg, Germany.
⁴ University of Minnesota, Minneapolis VA Medical Center, Minneapolis, MN, USA.
⁵ Umea University, Department of Public Health and Clinical Medicine, Umea, Sweden.
⁶ Novartis Pharmaceuticals, East Hanover, NJ, USA.

Comment

Jadwiga A Wedzicha et al. Lancet Respir Med. 2013 Jul.

. 2013 Jul;1(5):e23.

doi: 10.1016/S2213-2600(13)70104-8. Epub 2013 Jul 8.

¹ Centre for Respiratory Medicine, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: w.wedzicha@ucl.ac.uk.
² Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium.
³ Paracelsus Medical University Nuremberg, Nuremberg, Germany; Klinikum Nuernberg, Department of Respiratory Medicine, Allergology, Sleep Medicine, Nuernberg, Germany.
⁴ University of Minnesota, Minneapolis VA Medical Center, Minneapolis, MN, USA.
⁵ Umea University, Department of Public Health and Clinical Medicine, Umea, Sweden.
⁶ Novartis Pharmaceuticals, East Hanover, NJ, USA.

No abstract available

Comment on

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.
Wedzicha JA, Decramer M, Ficker JH, Niewoehner DE, Sandström T, Taylor AF, D'Andrea P, Arrasate C, Chen H, Banerji D. Wedzicha JA, et al. Lancet Respir Med. 2013 May;1(3):199-209. doi: 10.1016/S2213-2600(13)70052-3. Epub 2013 Apr 23. Lancet Respir Med. 2013. PMID: 24429126 Clinical Trial.
QVA149 versus glycopyrronium for COPD.
Van Meerhaeghe A, Vanhaeverbeek M. Van Meerhaeghe A, et al. Lancet Respir Med. 2013 Jul;1(5):e22-3. doi: 10.1016/S2213-2600(13)70115-2. Epub 2013 Jul 8. Lancet Respir Med. 2013. PMID: 24429209 No abstract available.